New study hopes to unlock secrets of rare brain condition in children
NCT ID NCT07421219
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will follow 50 children aged 5 to 8 with non-progressive congenital ataxia, a rare condition that affects movement and coordination. Researchers will use detailed exams, brain scans, and genetic testing to better understand the disorder and its impact on quality of life. The goal is to improve diagnosis and pave the way for future targeted treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better diagnostic tools and targeted therapies for children with non-progressive congenital ataxia.
- What could go wrong
- This is an observational study, not a treatment trial, so no direct benefit to participants. It is small (50 children) and early-stage, so findings may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATAXIC CEREBRAL PALSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus, Denmark
-
IASO Children's Hospital
Athens, Greece
-
KU Leuven
Leuven, Belgium
-
Queen Silvia Children's Hospital at Sahlgrenska University Hospital
Gothenburg, 416 50, Sweden
-
Toulouse University Hospital
Toulouse, France
-
University Hospital Tübingen
Tübingen, Germany
-
Vestfold Hospital Trust
Tønsberg, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.